CKD-MBD Working Group
Chronic Kidney Disease – Mineral and Bone Disorder Working Group
The clinical “syndrome” of CKD-MBD has been recognized as an important contributor to morbidity and mortality throughout all stages of CKD. In the past, research centres have traditionally and individually focused on some isolated aspects of this newly recognized entity. Nevertheless, CKD-MBD is a complex interaction of multiple disturbances finally resulting in heterogeneous sequelae.
Large-scale cooperation between centres with a special interest in these matters is of key relevance in order to achieve a global and translational approach to the pathophysiology, prevention and treatment of CKD-MBD.
To this end, the CKD-MBD Working Group aims to work as a common platform for educational, intellectual and personal exchange to facilitate research in the field of Chronic Kidney Disease – Mineral and Bone Disorder.
Join this working group
Being an ordinary member of the CKD-MBD Working Group means being part of a network which facilitates exchanges of ideas on basic science research and new treatment protocols.
Becoming an ordinary member of the CKD-MBD Working Group is free of charge and easy to do within your personal MyERA. Ordinary members must be ERA members and persons with a proven interest in the research area covered by the WG.
By joining the CKD-MBD Working Group you will receive periodic newsletters with updates on the Working Group initiatives: e-seminars, CMEs, research projects and networking opportunities.
Management of fracture risk in CKD – traditional and novel approaches
Differentiating the causes of adynamic bone in advanced chronic kidney disease informs osteoporosis treatment
Bone evaluation in paediatric chronic kidney disease: Clinical practice points from the ESPN CKD-MBD and Dialysis Wg and CKD-MBD Wg
European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4–G5D
CKD-MBD related publications in the ERA journals
The ERA acknowledges the high clinical and scientific relevance of the CKD-MBD syndrome, reflected by several key publications in the journals of our society. We hereby summarize the content of several recent important papers, providing a link to their abstracts.
CKD-MBD: back to the future. Which D for which patient?
Silverio Rotondi, Italy
Mario Cozzolino, Italy
Markus Ketteler, Germany
Adriana Dusso, United States
The CKD-MDB Board provides strategic direction to the working group. Board members enchance exchange of expertise and international cooperation.
Mathias Loberg Haarhaus
Carlo Alfieri, Italy
Jordi Bover, Spain
Etienne Cavalier, Belgium
Martin de Borst, The Netherlands
Maria Fusaro, Italy
Mehmet Kanbay, Turkey
Markus Ketteler, Germany
Smeeta Sinha, United Kingdom
Events organised by CKD-MBD
6th European Renal Osteodystrophy (EUROD) Winter Meeting
January 19-21, 2023, Leuven, Belgium
5th European Renal Osteodystrophy (EUROD) Winter Meeting
January 20-21, 2022, Leuven, Belgium
4th European Renal Osteodystrophy (EUROD) Winter Meeting
January 14-15, 2021, Fully virtual
Nephrology Virtual Preceptorship: Fracture Prevention in CKD
December 4, 2020, Leuven, Belgium
3rd European Renal Osteodystrophy (EUROD) Winter meeting
January 18, 2020, Leuven, Belgium
The challenge of osteoporosis in CKD
January 18, 2019, Leuven, Belgium
EuReCa-M and CKD-MBD meeting
September 13-15, 2018, Thessaloniki, Greece
The role of bone biopsy in clinical practice
January 19, 2018, Leuven, Belgium